RetinAI develops certified software solutions to enable the right decisions sooner in clinics and pharma, making institutions more efficient with insights and knowledge from data. Our software collects, organizes and analyzes health data from clinic level all the way to global scale pharma studies. Our 1st product, RetinAI Discovery, is redefining the industry standards, enabling improved management and oversight of clinical studies and real time monitoring and analysis of data, increasing the process efficiency and paving the way for distribution of personalized digital precision medicine.

News

16.10.2024 USD 8M and a strategic partner for Ikerian AG (startupticker.ch)
25.04.2023 RetinAI joins forces with Boehringer Ingelheim (startupticker.ch)
30.09.2022 RetinAI establishes presence in the US market (startupticker.ch)
02.05.2022 RetinAI Discovery achieves FDA clearance (startupticker.ch)
07.04.2022 Swiss Economic Award: Das sind die Finalisten (startupticker.ch)
06.08.2021 RetinAI on a fast-paced growth course (startupticker.ch)

Milestones/News